Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 3/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL471865 | 0.84 | ADRA2A (0.44) | ADRA2AADRA2BADRA2CADRA1AGMNN | |
| SCHEMBL11743173 | 0.75 | ADRA2A (0.38) | ADRA2AADRA2BADRA2CADRA1AGMNN | |
| SCHEMBL961726 | 0.71 | ADRA2A (0.44) | ADRA2AADRA2BADRA2CADRA1AGMNN | |
| SCHEMBL961378 | 0.70 | ADRA2A (0.47) | ADRA2AADRA2BADRA2CADRA1AGMNN | |
| Hydrogen Sulfide SCHEMBL721911 | 0.68 | ADRA2A (0.46) | ADRA2AADRA2BADRA2CADRA1AGMNN | |
| SCHEMBL11740603 | 0.67 | — | — | |
| SCHEMBL19612832 | 0.66 | — | — | |
| SCHEMBL2778023 | 0.66 | ADRA2A (0.38) | ADRA2AADRA2BADRA2CADRA1AGMNN | |
| SCHEMBL543405 | 0.65 | ADRA2A (0.39) | ADRA2AADRA2BADRA2CADRA1AGMNN | |
| SCHEMBL2782843 | 0.64 | ADRA2A (0.37) | ADRA2AADRA2BADRA2CADRA1AGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11073495-B2 | Biosensor and manufacturing method of biosensor | ARKRAY, INC. (JP) | 2021-07-27 | — | — | US | claimed |
| WO-2024143457-A1 | ADHESIVE COMPOSITION, ADHESIVE SHEET, MULTILAYER BODY, AND DISPLAY PROVIDED WITH SAID MULTILAYER BODY | ａｒｔｉｅｎｃｅ株式会社 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024106276-A1 | POLYMER FOR TEXTILE PRINTING INK, EMULSION FOR TEXTILE PRINTING INK CONTAINING SAID POLYMER, AND TEXTILE PRINTING INK | 株式会社日本触媒 | 2024-05-23 | — | — | WO | disclosed |
| EP-3037812-B1 | ENZYME ELECTRODE | ARKRAY INC (JP) | 2024-05-01 | — | — | EP | disclosed |
| CN-117626687-A | Treatment liquid composition for dye printing, composition set, printing method and inkjet printing method | 精工爱普生株式会社 | 2024-03-01 | — | — | CN | disclosed |
| CN-117529533-A | Ink for inkjet textile printing, method for manufacturing printed matter using the same, and article having attached image | 株式会社日本触媒 | 2024-02-06 | — | — | CN | disclosed |
| EP-3156789-B1 | BIOSENSOR | ARKRAY INC (JP) | 2024-01-03 | — | — | EP | disclosed |
| CN-115003765-B | Ink for inkjet | 株式会社日本触媒 | 2023-11-28 | — | — | CN | disclosed |
| CN-116607339-A | Treatment liquid composition for dye printing, composition set, printing method and inkjet printing method | 精工爱普生株式会社 | 2023-08-18 | — | — | CN | disclosed |
| US-20230257589-A1 | Dye Printing Treatment Liquid Composition, Composition Set, Printing Method, And Ink Jet Printing Method | SEIKO EPSON CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| US-7919149-B2 | Carbodiimide compound and waterborne curable resin composition containing thereof | NIPPON PAINT CO., LTD. (JP) | 2011-04-05 | — | — | US | disclosed |
| US-7799869-B2 | Thermoplastic elastomer composition and molded article | KANEKA CORPORATION (JP) | 2010-09-21 | — | — | US | disclosed |
| US-7691451-B2 | Composite powder coating material, process for production thereof and method for the color matching of powder coating material | KANSAI PAINT CO., LTD. (JP) | 2010-04-06 | — | — | US | disclosed |
| US-20090171016-A1 | Carbodiimide Compound and Waterborne Curable Resin Composition Containing Thereof | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20080131714-A1 | WATER-BASED INTERMEDIATE COATING COMPOSITION AND METHOD FOR FORMING MULTILAYER COATING FILM | NIPPON PAINT CO., LTD. (JP) | 2008-06-05 | — | — | US | disclosed |
| US-20070299196-A1 | Composite Powder Coating Material, Process for Production Thereof and Method for the Color Matching of Powder Coating Material Technical Field | KANSAI PAINT CO., LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
| US-20070173604-A1 | Thermoplastic elastomer composition and molded article | KANEKA CORPORATION (JP) | 2007-07-26 | — | — | US | disclosed |
| EP-1714993-A1 | THERMOPLASTIC ELASTOMER COMPOSITION AND MOLDED ARTICLE | KANEKA CORPORATION (JP) | 2006-10-25 | — | — | EP | disclosed |
| US-20040134791-A1 | Water-based intermediate coating composition and method for forming multilayer coating film | NIPPON PAINT CO., LTD. (JP) | 2004-07-15 | — | — | US | disclosed |
| US-5254664-A | Containing a 2-oxazoline group; molding materials | NIPPON SHOKUBAI CO., LTD. (JP) | 1993-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090171016-A1 | Carbodiimide Compound and Waterborne Curable Resin Composition Containing Thereof | JMJD6, ARCN1, WDR1 | ADRA2A 3994/4885ADRA2B 3979/4885ADRA2C 4518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.